EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In vitro activity of ebselen as monotherapy and in combination with itraconazole against Sporothrix brasiliensis

Diulien Canary de Lima, Vanice Rodrigues Poester, Mariana Rodrigues Trápaga, Bruna Muradás Esperon, Emília Ferreira Andrade, Jessica Estefania Davila Hidalgo, Rosely Maria Zancopé-Oliveira, Rodrigo Almeida-Paes, Cristina Wayne Nogueira, Gilson Zeni, Melissa Orzechowski Xavier

Revista Iberoamericana de Micología · 2026-10

DOI: 10.1016/j.riam.2026.09.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista Iberoamericana de Micología, 2026-10. Verfasst von Diulien Canary de Lima und 10 weiteren Autor:innen. Beteiligte Einrichtung: Pós Graduação em Ciências da Saúde, Faculdade de Medicina/Universidade Federal do Rio Grande (FAMED/FURG), Rio Grande, Rio Grande do Sul (RS), Brazil. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FAPERGS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Sporotrichosis caused by Sporothrix brasiliensis is a growing public health concern with limited therapeutic options and the emergence of non-wild-type isolates. Ebselen is a synthetic molecule intended for the potential treatment of some diseases; this organoselenium molecule underwent a Phase II clinical experience. AIMS: In view of the preceding clinical trials, this investigation aimed to establish the anti-S. brasiliensis activity of ebselen in monotherapy and in combination with itraconazole. METHODS: Twenty-five isolates were evaluated by microdilution assays to determine partial (MICp) and total (MICt) minimum inhibitory concentrations, minimum fungicidal concentrations (MFCs), and fungicidal/fungistatic activity based on the MFC/MICt ratio (≤2, fungicidal; >2, fungistatic). Checkerboard assays were performed to evaluate the interaction between ebselen and itraconazole, classified as synergistic, indifferent, or antagonistic. RESULTS: Ebselen inhibited partially and completely all the isolates tested, with a geometric mean MICp of 0.5 µg/mL (range: 0.25-2 µg/mL) and MICt of 2.6 µg/mL (range: 0.5-16 µg/mL), including S. brasiliensis isolates classified as non-wild type in relation to itraconazole susceptibility (n=8). MFC values were determined for 18 isolates (72%; 18/25), ranging from 4 to 16 µg/mL (GM: 8.6 µg/mL), and a fungicidal effect was observed in 39% (7/18) of these isolates. Synergism with itraconazole was observed in 56% (14/25) of the isolates, resulting in a reduction of itraconazole MIC values to levels consistent with those of the wild-type phenotype in five isolates originally classified as non-wild-type. CONCLUSIONS: Ebselen has excellent in vitro performance against S. brasiliensis; therefore, further in vivo studies are required to validate its potential for the treatment of sporotrichosis.

Schlagwörter

Stichwörter der Autor:innen

AntifungalsAntifúngicosEsporotricosisOrganoselenioOrganoseleniumSelenioSeleniumSporotrichosisZoonosis

Autor:innen und Institutionen

  • Pós Graduação em Ciências da Saúde, Faculdade de Medicina/Universidade Federal do Rio Grande (FAMED/FURG), Rio Grande, Rio Grande do Sul (RS), Brazil.
  • Pós Graduação em Ciências da Saúde, Faculdade de Medicina/Universidade Federal do Rio Grande (FAMED/FURG), Rio Grande, Rio Grande do Sul (RS), Brazil. Electronic address: vanicerp@gmail.com.
  • Laboratório de Micologia, Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil.
  • Laboratório de Síntese, Reatividade e Avaliação Farmacológica e Toxicológica de Organocalcogênios, Universidade Federal de Santa Maria (UFSM), Santa Maria, RS, Brazil.
  • Pós Graduação em Ciências da Saúde, Faculdade de Medicina/Universidade Federal do Rio Grande (FAMED/FURG), Rio Grande, Rio Grande do Sul (RS), Brazil. Electronic address: melissaxavierfurg@gmail.com.

Förderung

  • FAPERGS

Zitieren

APA

de Lima, D. C., Poester, V. R., Trápaga, M. R., Esperon, B. M., Andrade, E. F., Hidalgo, J. E. D., Zancopé-Oliveira, R. M., Almeida-Paes, R., Nogueira, C. W., Zeni, G., & Xavier, M. O. (2026). In vitro activity of ebselen as monotherapy and in combination with itraconazole against Sporothrix brasiliensis. Revista Iberoamericana de Micología. https://doi.org/10.1016/j.riam.2026.09.002

Vancouver

de Lima DC, Poester VR, Trápaga MR, Esperon BM, Andrade EF, Hidalgo JED, et al. In vitro activity of ebselen as monotherapy and in combination with itraconazole against Sporothrix brasiliensis. Revista Iberoamericana de Micología. 2026. doi:10.1016/j.riam.2026.09.002

BibTeX
@article{deLima2026,
  author = {de Lima, Diulien Canary and Poester, Vanice Rodrigues and Trápaga, Mariana Rodrigues and Esperon, Bruna Muradás and Andrade, Emília Ferreira and Hidalgo, Jessica Estefania Davila and Zancopé-Oliveira, Rosely Maria and Almeida-Paes, Rodrigo and Nogueira, Cristina Wayne and Zeni, Gilson and Xavier, Melissa Orzechowski},
  title = {In vitro activity of ebselen as monotherapy and in combination with itraconazole against Sporothrix brasiliensis},
  journal = {Revista Iberoamericana de Micología},
  year = {2026},
  doi = {10.1016/j.riam.2026.09.002}
}
Kostenlos starten →